UUID:E51D8CCE-6A49-4A72~966E-FA396483FOCCd
TCGA- LN— A5U6— BlA- PR

III IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII

III II IIIIIIIIIIIIIIIIIIII
IIIIIIIIIIIII'III'IIIII'I'I'III'IIIIII'IIIIII'III'IIIIIIIIIIIIIIIIII

 

 

I I
. . . Iowa 35
Lllmcal Case Report (gramm‘? mused/N65
(F0? 0 ssue) 862)) 5
Pm Luger ‘fh L4 :1? 65
@% “laid-m A :27 5 S
F 15 W
04 as] (L155
IInformed Consentl S49 [6/13
I personally informed this natient that a specimen(s} would be collected to be used for research ‘-
purposes I renewed the EARCH SUBJECT INFORMATION AND CONSENT

FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act A copy of this informed consent document will be retained at

our institution.

Name of Physician or Study Coordinator ”

 

Elinical Informationf

 

 

 

 

TION
I .7 fﬂ "a 2, 1:] Single Married 3‘?”
Gender 13 Divorced D Widow Blood Pressure Heart Rate
DFemale 50 Y NV? 8 Z.
. HISTORY OFIPRESENT ILLNESS
Chief Complalnts: {a 11):! ) ’I m LL) la. 8‘ Waﬂow Iva,
Symptoms: M. {.01 k t Gm I (mm; Ybualiic'tklnj

 

Clinical Findings:

 

Performance Scale (Karnofsky Score):
:1 100 Asymptomatic u 80- 90 Symptomatic but Fully Ambulatory 0-70 Symptomatic,‘ 111 bed less than 50% of day
a 40~50 Symptomatic, in bed more than 50% of day, but 11 t bed ridden 1:1 20- 30 Bed Ridden

 

 

 

CURRENT MEDICATIONS

 

 

PAST MEDICAL HISTORY
Disease Disorder

Treatment

 

 

 

 

 

 

OBIGYN HISTORY
Menopausal Status Date of First Menses # of Pregnancies
Cl Pro-menopausal
CI Peri-Menopausal Date of Last Menses # of Live Births
D Post-menopausal

 

 

 

Birth Control: D Condom El Oral Contraceptive

c1 IUD [:1 Hormone Replacement

Therapy:

 

El Other:

 

Current Status
is YES IS NO

ﬁYES UNO

Current Status

EYES

NO

 

 

SOCIAL HISTORY
Environmental Hazards:

H

:1 an: / Am 1 a
Alcohol
Drinks
m rt '

Use

FAMILY MEDICAL HISTORY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LAB DATA

Test Result I Date I I I Test Result Date
HIV ﬁaNegative {:1 Positive: CEA {3 Negative 13 Positive:

Hep B ﬁNegative 13 Positive: CA 153 O Negative El Positive:

Hep C {9 Negative El Positive: CA 19-9 :1 Negative 1:: Positive: ‘
AFP :1 Negative D Positive: PSA El Negative El Positive: . __

Other: Cl Negative Cl Positive: Other: :1 Negative El Positive:

"BIT Cell Markers:

 

 

DIAGNOSTIC STUDIES

Ultrasound
X-Ra
CT

NIRI
B. (I i 1L “4.x '

CLINICAL DIAGNOSIS
L 6‘4 MW

Location of Metastasis

Dateof
71 N M Stage: ‘

 

 

[Treatment Information}

. SURGICAL TREATMENT
Date of Procedure

CLLwc’nA-m c»._ “'2 Qob‘p 3

Fri ' Tumor
Detailed Location

I

Extension of Tumor

l. Nodes
Location of Nodes
Palpable, Non-Dissected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis

Su ical
T N

NEOADJUVENT THERAPY
Route

 

Pathology Form

 

[Specimen Information}

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Collected by: _ Date: Cime:__
Preserved by: ___ Date; fime:__
,V SPECIMEN TYPE (# of samples provided)
Frozen Parafﬁn Block Blood/Serum/Plasma Slide
Diseased Normal Diseased Normal Diseased Normal . Diseased Normal
. z 4 2 a 2~
1 Time to LN2 Time to Formalin Time to LN2
1y min //f min min
. PATHOLOGICAL DESCRIPTION
Primary Tumor
Organ Size Extension of Tumor Distance to NAT
eéo 9%. g1; Za/Méﬂ .4; x ‘3 x '2 cm WM 7219?”? 6 cm
: ______~_______; L'ymph Nodes
W. Lu“ ,_ .4; # Examined # Metastasized
Distant Metastasis
Organ Detailed Location Size
Pathological Staging
.pTZ_ N4 M 0 Stage: I]: [3

 

 

Notes:

.%;7€%>Morgy 2 (WZ’ue/é #4792501? 1)

 

 

Consolidated Pathology Diagnosis

- Adenomatous

Cell

Cellular Differentiation:

Nuclear

Giant Cell

Nuclear Grade:

 

[Final Pathology Report]

”steal/79ml Diasnoesiis59¢signiﬁes;“Qt/i£14.sf2;_.27“o\_~.2;6mule:...._.________‘L

1' mammmskxigae +5 4127/

 

 

 

Comments:

 

 

D! 6’42 Dots/37 79255? 02,462 ﬂew

Date

(a) 0" I7 I) m m
INTEGRATED REPORT OF FINDINGS BY‘ '

 

